Tags

Type your tag names separated by a space and hit enter

Liver injury in COVID-19: management and challenges.
Lancet Gastroenterol Hepatol. 2020 05; 5(5):428-430.LG

Authors+Show Affiliations

Treatment and Research Center for Infectious Diseases, The Fifth Medical Center of PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing 100039, China.Treatment and Research Center for Infectious Diseases, The Fifth Medical Center of PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing 100039, China.Treatment and Research Center for Infectious Diseases, The Fifth Medical Center of PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing 100039, China. Electronic address: fswang302@163.com.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

32145190

Citation

Zhang, Chao, et al. "Liver Injury in COVID-19: Management and Challenges." The Lancet. Gastroenterology & Hepatology, vol. 5, no. 5, 2020, pp. 428-430.
Zhang C, Shi L, Wang FS. Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol. 2020;5(5):428-430.
Zhang, C., Shi, L., & Wang, F. S. (2020). Liver injury in COVID-19: management and challenges. The Lancet. Gastroenterology & Hepatology, 5(5), 428-430. https://doi.org/10.1016/S2468-1253(20)30057-1
Zhang C, Shi L, Wang FS. Liver Injury in COVID-19: Management and Challenges. Lancet Gastroenterol Hepatol. 2020;5(5):428-430. PubMed PMID: 32145190.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Liver injury in COVID-19: management and challenges. AU - Zhang,Chao, AU - Shi,Lei, AU - Wang,Fu-Sheng, Y1 - 2020/03/04/ PY - 2020/02/28/received PY - 2020/03/01/accepted PY - 2020/3/8/pubmed PY - 2020/4/16/medline PY - 2020/3/8/entrez SP - 428 EP - 430 JF - The lancet. Gastroenterology & hepatology JO - Lancet Gastroenterol Hepatol VL - 5 IS - 5 SN - 2468-1253 UR - https://www.unboundmedicine.com/medline/citation/32145190/full_citation L2 - https://linkinghub.elsevier.com/retrieve/pii/S2468-1253(20)30057-1 DB - PRIME DP - Unbound Medicine ER -